Paniagua-Contreras GL, Monroy-Pérez E, Vaca-Pacheco S, Valle-Patiño AG, González-Almazán SE

Language: Spanish
References: 27
Page: 68-74
PDF size: 98.57 Kb.

ABSTRACT

Age, male gender, high levels of total cholesterol or low density lipoprotein cholesterol (LDL), increased blood pressure, tobaccoism, diabetes mellitus and familial antecedents of premature coronary cardiopathy are risk factors for atherosclerosis development. The purpose of this work was to detect the principal risk factors for atherosclerosis in a group of ambulatory patients from Los Reyes Iztacala, Tlalnepantla, Estado de México. One hundred and sixty patients were analyzed. Serum concentrations of total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides, and glucose were determined. An inquiry was applied to the patients in order to detect other risk factors for cardiovascular disease as: myocardium infarct, tobaccoism and blood hypertension. Forty-six percent of the patients analyzed had elevated total cholesterol concentrations, 27.5% had increased HDL-cholesterol levels, 13% and 5% higher than normal LDL-cholesterol or VLDL-cholesterol values, respectively; 35% had hypertriglyceridemia and 48.75% showed hyperglycaemia. Among patients with increased LDL-cholesterol serum concentrations, women showed a higher association with other risk factors as hypercholesterolemia, diabetes, familial antecedents of myocardium infarct, tobaccoism and blood hypertension. In this study 1.25% and 21.87% of the patients were detected as in high or moderate risk for developing atherosclerosis, respectively. We believe that it is very important to provide complete information about atherosclerosis risk factors to people in order to diminish their impact on health.

REFERENCES

1. Estadísticas vitales. Secretaría de Salud. 1990; INEGI.

2. González V, García A, Sánchez C. Isquemia miocárdica silenciosa: un problema de diagnóstico y tratamiento. Arch Inst Rev Cardiol Méx 1989; 59: 567-571.

3. Cueto-García L. Prevención de la aterosclerosis en México. México, D.F. Intersistemas 1989: 185-197.

4. Estadísticas de Mortalidad. Secretaría de Salud. 1992: INEGI.

5. American College of Physicians Guidelines for using serum cholesterol, high-density lipoprotein cholesterol and triglyceride levels as sceening test for preventing coronary heart disease in adults. Ann Intern Med 1996; 124: 515-517.

6. Lozano-Ascencio R, Escamilla-Cejudo JA, Escobedo-de la Peña J, López-Cervantes M. Tendencia de la mortalidad por cardiopatía isquémica en México, de 1950 a 1985. Sal Pub Mex 1990; 32: 405-415.

7. Henry RJ. Clinical chemistry, principles and techniques. New York: Harper & Row Publishers, 1974.

8. Lopes-Virella MF, Stone P, Ellis S, Cowell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-884.

9. Soloni FG. Simplified manual micromethod for determination of serum triglycerides. Clin Chem 1971; 17: 529-534.

10. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22: 158-161.

11. Quibrera IR, Hernández RH, Aradillas GC, González RS, Calles EJ. Prevalencia de diabetes, intolerancia a la glucosa, hiperlipidemia y factores de riesgo en función del nivel socioeconómico. Rev Invest Clin 1994; 46: 23-26.

12. Posadas-Romero C, Sepúlveda J, Tapia-Coyer R, Magos C, Cardoso-Saldaña G et al. Valores de colesterol sérico en la población mexicana. Sal Pub Mex 1992; 34: 157-167.

13. Salgado-Sales P. Estudio epidemiológico de colesterol en población de Acapulco, México. Sal Pub Mex 1992; 34: 653-658.

14. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalasa Hearth Study. Am J Epidemiol 1991; 133: 884-999.

15. Egan BM, Basset D, Block WD. Comparative effects of overweight on cardiovascular risk in younger versus older men. Am J Cardiol 1991; 67: 52-248.

16. Kazumi T, Kawaguchi A, Hozumi T, Ishida Y, Yoshino G. Serum HDL cholesterol values are associated with apoB-containing lipoprotein metabolism and triglyceride-body fat interrelation in young Japanese men. Atherosclerosis 1997; 130: 93-100.

17. Wilt TJ, Davis BR, Meyers DG, Rouleau JL, Sacks FM. Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL; baseline results from the Cholesterol and Recurrent Events (CARE) Study. Angiology 1996; 47: 533-541.

18. National Cholesterol Education Program. Second report of the expert panel on detection, and treatment of high blood cholesterol in adults (adult treatment panel I). Bethesda, National Heart, Lung, and Blood Institute. NIH publication. 1993: 93-3095.

19. Goldstein JL, Browner WS. Familial hypercholesterolemia. In: Sturnbury JB, Wyngarden JB, Fredrickson DS, Goldstein JL, Brown MS. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983: 672-712.

20. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Tromb Vasc Biol 1997; 17: 95-106.

21. Postorino G, Altavilla R, Fantozzi G, Provenzano B, Cappelli R, Forconi S. Is there a relationship between sex, age, Lp(a) blood levels, lipid values, and atherosclerotic carotid lesions? Minerva Med 1996; 87: 379-383.

22. Castelli WP, Garrison RJ, Wilson PWF, Abott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. Jama 1986; 256: 2835-2838.

23. Carlsson LA, Bottiger LE. Ischemic heart disease in relation to fasting levels of plasma triglycerides and cholesterol. Stockholm Prospective Study. Lancet. 1972; 1: 865.

24. Vulkov I. Percentile reference values of lipid risk factors of ischaemic heart disease: Cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides in individuals aged 20 to 60 years in Plovdiv region. Folia Med (Plovdiv). 1997; 39: 37-45.

25. Thompson GR. Secondary hyperlipidemia. A handbook of hyperlipidemia. Londres: Current Science, 1989: 143-159.

26. Katsilambros NI, Tsapogas PC, Arvanitis MP, Tritos NA, Alexiou ZP Rigas K L. Risk factors for lower extremity arterial disease in non-insulinodependent diabetic persons. Diabet Med 1996; 13: 243-246.

27. Kawasuji M, Kawajiri F, Watanabe G, Matsunaga Y, Tediriya Y, Iwa T. Coronary bypass surgery for familial hypercholesterolemia. Jpn J Thorac Surg 1988; 41: 537-540.